Related Experiment Video
Updated: Sep 18, 2025
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Sleep Quality, Depression, and Frailty in Atrial Fibrillation Patients: The Mediating and Interaction Effects
Hairong Lin1, Xue Yang2, Guirong Li3
1Department of Gastroenterology, Mianyang Central Hospital, Mianyang, Sichuan, China.
Purpose:
Frailty, sleep disorders, and depression are common issues among patients with atrial fibrillation (AF) although the underlying mechanisms are not yet clear. This study aims to explore the mediating role of depression between sleep and frailty and the interactive effects of sleep and depression on frailty in patients with AF.
Methods:
We conducted a cross-sectional study that enrolled 380 AF patients in Tianjin, China. The Mental Health Inventory-5, the Pittsburgh Sleep Quality Index, and the FRAIL scale were used to detect depression, sleep quality, and frailty. The Mediator and interaction effects were tested among them.
Results:
Sleep quality had a positive effect on depression (a = 0.135, p < 0.001). Sleep quality had a positive effect on frailty (b = 0.089, p < 0.001). Depression partially mediates the relationship between sleep quality and frailty with the mediating effect was 14.8%. Further, sleep disorders and depression have an additive interactive effect to synergistically increase the risk of frailty (OR = 8.94, 95% CI: 4.36-18.3, p < 0.001) which is strongly indicated by the RERI = 5 (95% CI: 0.14-13.25), Ap = 0.51 (95% CI: 0.07-1.63), and S = 3.13 (95% CI: 1.26-19.84).
Conclusion:
Depression partially mediates between sleep and frailty in AF patients. AF patients exposed to both sleep disorders and depression have a superposed risk of frailty. In clinical practice, A variety of interventions should be considered to improve sleep quality and depression to reduce the risk of frailty.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
01:24Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:14Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
01:13Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
01:23Antidepressant Drugs: MAOIs and Other Agents
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...